GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alphatec Holdings Inc (NAS:ATEC) » Definitions » EV-to-Revenue

ATEC (Alphatec Holdings) EV-to-Revenue : 3.50 (As of May. 25, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Alphatec Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Alphatec Holdings's enterprise value is $2,247.9 Mil. Alphatec Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $642.3 Mil. Therefore, Alphatec Holdings's EV-to-Revenue for today is 3.50.

The historical rank and industry rank for Alphatec Holdings's EV-to-Revenue or its related term are showing as below:

ATEC' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.29   Med: 2.98   Max: 9.28
Current: 3.5

During the past 13 years, the highest EV-to-Revenue of Alphatec Holdings was 9.28. The lowest was 0.29. And the median was 2.98.

ATEC's EV-to-Revenue is ranked worse than
54.32% of 821 companies
in the Medical Devices & Instruments industry
Industry Median: 3.11 vs ATEC: 3.50

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-25), Alphatec Holdings's stock price is $12.45. Alphatec Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $4.45. Therefore, Alphatec Holdings's PS Ratio for today is 2.80.


Alphatec Holdings EV-to-Revenue Historical Data

The historical data trend for Alphatec Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphatec Holdings EV-to-Revenue Chart

Alphatec Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.78 5.37 4.64 5.03 2.93

Alphatec Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.53 3.57 2.22 2.93 2.99

Competitive Comparison of Alphatec Holdings's EV-to-Revenue

For the Medical Devices subindustry, Alphatec Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alphatec Holdings's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alphatec Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Alphatec Holdings's EV-to-Revenue falls into.


;
;

Alphatec Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Alphatec Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2247.881/642.265
=3.50

Alphatec Holdings's current Enterprise Value is $2,247.9 Mil.
Alphatec Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $642.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alphatec Holdings  (NAS:ATEC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Alphatec Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=12.45/4.446
=2.80

Alphatec Holdings's share price for today is $12.45.
Alphatec Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.45.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alphatec Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Alphatec Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Alphatec Holdings Business Description

Traded in Other Exchanges
Address
1950 Camino Vida Roble, Carlsbad, CA, USA, 92008
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Executives
Scott Lish officer: SVP, Development C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
John Todd Koning officer: Chief Financial Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Patrick Miles director, officer: Executive Chairman 7475 LUSK BLVD., SAN DIEGO CA 92121
David Sponsel officer: EVP, Sales C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
Karen K Mcginnis director INSIGHT ENTERPRISES INC, 1305 WEST AUTO DRIVE, TEMPE AZ 85284
Evan Bakst director 225 CENTRAL PARK WEST, APT. 1605, NEW YORK NY 10024
David R Pelizzon director, 10 percent owner 2850 FRONTIER DR, WARSAW IN 46582
David M Demski director C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Tyson Eliot Marshall officer: GENERAL COUNSEL & CORP. SEC. 10680 TREENA STREET, SUITE 500, SAN DIEGO CA 92131
Quentin S. Blackford director 7475 LUSK BLVD., SAN DIEGO CA 92121
Craig E Hunsaker officer: See Remarks C/O ALPHATEC HOLDINGS, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
David H Mowry director 9775 TOLEDO, IRVINE CA 92618
Tullis James L L director, 10 percent owner 100 FIRST STAMFORD PLACE, STAMFORD CT 06907
Jennifer N. Pritzker 10 percent owner C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121